These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25096855)

  • 21. Anti-angiotensin II type 1 receptor autoantibodies (AT
    İlgen U; Yayla ME; Düzgün N
    Rheumatol Int; 2017 Apr; 37(4):593-598. PubMed ID: 28004166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel retro-inverso peptide inhibitor reverses angiotensin receptor autoantibody-induced hypertension in the rabbit.
    Li H; Kem DC; Zhang L; Huang B; Liles C; Benbrook A; Gali H; Veitla V; Scherlag BJ; Cunningham MW; Yu X
    Hypertension; 2015 Apr; 65(4):793-9. PubMed ID: 25691619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monocytic Angiotensin and Endothelin Receptor Imbalance Modulate Secretion of the Profibrotic Chemokine Ligand 18.
    Rademacher J; Kill A; Mattat K; Dragun D; Siegert E; Günther J; Riemekasten G
    J Rheumatol; 2016 Mar; 43(3):587-91. PubMed ID: 26773103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor increases pulmonary vascular permeability in cystic fibrosis patients undergoing lung transplantation.
    Krenn K; Klepetko W; Taghavi S; Paulus P; Aharinejad S
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):35-41. PubMed ID: 17481912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of non-HLA and anti-HLA antibodies: incidence and importance in renal transplantation.
    Banasik M; Boratyńska M; Kościelska-Kasprzak K; Mazanowska O; Bartoszek D; Zabińska M; Myszka M; Nowakowska B; Hałoń A; Szyber P; Patrzałek D; Klinger M
    Transplant Proc; 2013 May; 45(4):1462-5. PubMed ID: 23726597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis.
    Kill A; Tabeling C; Undeutsch R; Kühl AA; Günther J; Radic M; Becker MO; Heidecke H; Worm M; Witzenrath M; Burmester GR; Dragun D; Riemekasten G
    Arthritis Res Ther; 2014 Jan; 16(1):R29. PubMed ID: 24472528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of functional autoantibodies against vascular receptors in systemic sclerosis.
    Riemekasten G; Philippe A; Näther M; Slowinski T; Müller DN; Heidecke H; Matucci-Cerinic M; Czirják L; Lukitsch I; Becker M; Kill A; van Laar JM; Catar R; Luft FC; Burmester GR; Hegner B; Dragun D
    Ann Rheum Dis; 2011 Mar; 70(3):530-6. PubMed ID: 21081526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibodies Toward the Angiotensin 2 Type 1 Receptor: A Novel Autoantibody in Alzheimer's Disease.
    Giil LM; Kristoffersen EK; Vedeler CA; Aarsland D; Nordrehaug JE; Winblad B; Cedazo-Minguez A; Lund A; Reksten TR
    J Alzheimers Dis; 2015; 47(2):523-9. PubMed ID: 26401573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A Receptor.
    Vythoulkas D; Lazana I; Kroupis C; Gavriilaki E; Konstantellos I; Bousiou Z; Chondropoulos S; Griniezaki M; Vardi A; Gkirkas K; Karagiannidou A; Batsis I; Stamouli M; Sakellari I; Tsirigotis P
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of angiotensin II type 1 receptor (AT1R)-activating autoantibodies in primary aldosteronism.
    Li H; Yu X; Cicala MV; Mantero F; Benbrook A; Veitla V; Cunningham MW; Kem DC
    J Am Soc Hypertens; 2015 Jan; 9(1):15-20. PubMed ID: 25537460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.
    Waters V; Yau Y; Prasad S; Lu A; Atenafu E; Crandall I; Tom S; Tullis E; Ratjen F
    Am J Respir Crit Care Med; 2011 Mar; 183(5):635-40. PubMed ID: 20889901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival benefit of induction immunosuppression in cystic fibrosis lung transplant recipients.
    Kirkby S; Whitson BA; Wehr AM; Lehman AM; Higgins RS; Hayes D
    J Cyst Fibros; 2015 Jan; 14(1):104-10. PubMed ID: 24948447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated levels of serum mucin-associated antigen in adult patients with cystic fibrosis.
    Robinson CB; Martin WR; Ratliff JL; Holland PV; Wu R; Cross CE
    Am Rev Respir Dis; 1993 Aug; 148(2):385-9. PubMed ID: 8342902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum anti-PAD4 autoantibodies are present in cystic fibrosis children and increase with age and lung disease severity.
    Linnemann RW; Yadav R; Zhang C; Sarr D; Rada B; Stecenko AA
    Autoimmunity; 2022 Mar; 55(2):109-117. PubMed ID: 35199621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Levels of Visfatin, Omentin and Irisin in Patients with End-Stage Lung Disease Before and After Lung Transplantation.
    Ochman M; Maruszewski M; Wojarski J; Żegleń S; Karolak W; Stanjek-Cichoracka A; Przybyłowski P; Zembala M; Kukla M
    Ann Transplant; 2017 Dec; 22():761-768. PubMed ID: 29277835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease.
    Vizza CD; Letizia C; Sciomer S; Naeije R; Della Rocca G; Di Roma A; Musarò S; Quattrucci S; Gaudio C; Battagliese A; Badagliacca R; D'Erasmo E; Fedele F
    Regul Pept; 2005 Jan; 124(1-3):187-93. PubMed ID: 15544858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of lung transplantation in patients with cystic fibrosis.
    Algar FJ; Cano JR; Moreno P; Espinosa D; Cerezo F; Alvarez A; Baamonde C; Santos F; Vaquero JM; Salvatierra A
    Transplant Proc; 2008 Nov; 40(9):3085-7. PubMed ID: 19010202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies in serum and sputum from patients with cystic fibrosis.
    Schiøtz PO; Egeskjold EM; Høiby N; Permin H
    Acta Pathol Microbiol Scand C; 1979 Oct; 87(5):319-24. PubMed ID: 117671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis.
    Zhao MH; Jayne DR; Ardiles LG; Culley F; Hodson ME; Lockwood CM
    QJM; 1996 Apr; 89(4):259-65. PubMed ID: 8733512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Angiotensin type 1 receptor antibodies in chronic graft-versus-host disease.
    Chiron A; Bouaziz JD; Carmagnat M; Peffault de Latour R; Lafaurie-Bergeron A; Robin M; Xhaard A; Toubert A; Charron D; Guigue N; Socié G; Bengoufa D
    Transplantation; 2014 Aug; 98(4):470-4. PubMed ID: 24873781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.